INR finger-prick test launched in pharmacies
A hand-held device that allows patients to monitor their INR at home via a finger-prick blood test has been launched in Australia.
The CoaguChek system provides results in a minute and tracks how often a patient’s INR is within or outside the therapeutic range.
The device, which has a recommended retail price of $695, will be sold by pharmacists. It can be set up to provide medication and testing reminders.
According to Roche, which manufactures the device, patients who frequently self-test spend more time in the therapeutic range.
Most patients (92%) will stay in range if they monitor their INR every three days.
Results can also be sent to a patient’s doctor or pharmacist so they can action abnormal results.